Poradosu Enrique 13D and 13G filings for Nuvectis Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-31 7:34 pm Purchase |
2023-12-31 | 13G | Nuvectis Pharma, Inc. NVCT |
Poradosu Enrique | 1,503,819 8.700% |
285,500 (+23.43%) |
Filing |
| 2023-02-13 5:15 pm Purchase |
2022-12-31 | 13G | Nuvectis Pharma, Inc. NVCT |
Poradosu Enrique | 1,218,319 8.300% |
1,218,319 (New Position) |
Filing |